Go offline with the Player FM app!
Oral GLP-1 agonist, Satiety Pathways, and Stem Cell tx for T1D
Manage episode 491179233 series 1110501
Program notes:
0:40 Stem cells for type 1 diabetes
1:40 None had hypoglycemia afterwards
2:40 Autologous stem cells?
3:20 Oral GLP-1 agonist
4:20 Primary endpoint HbA1c reduction
5:20 Weight loss modest
6:20 Injectable GLP-1 plus an amylin analogue
7:20 Both those with diabetes and those without
8:20 No increased safety events
8:40 Mental health hospitalizations in adolescents
9:40 KID database
10:40 Females accounting for increase
11:40 67% of hospitalizations
12:57 End
28 episodes
Manage episode 491179233 series 1110501
Program notes:
0:40 Stem cells for type 1 diabetes
1:40 None had hypoglycemia afterwards
2:40 Autologous stem cells?
3:20 Oral GLP-1 agonist
4:20 Primary endpoint HbA1c reduction
5:20 Weight loss modest
6:20 Injectable GLP-1 plus an amylin analogue
7:20 Both those with diabetes and those without
8:20 No increased safety events
8:40 Mental health hospitalizations in adolescents
9:40 KID database
10:40 Females accounting for increase
11:40 67% of hospitalizations
12:57 End
28 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.